MMS Testimony Concerning S 483 An Act Relative to Electronic Prescribing

Before the Joint Committee on Health Care Financing

The MMS strongly supports electronic prescription and medical record systems that are free from advertizing and promotional information. We support standards that require information to be evidence based and consistent with standards of care. We support the prompt initiation and efficient administration of any prior authorization programs payers may use. We support all these elements of S 483.

The MMS supports the sharing of formulary information with prescribers. We oppose any efforts to not show information regarding a payor's formulary, co-payment, or benefit plan. The MMS has worked for many years to help disseminate formulary information to physicians. It is not because we support formularies, we don't, unless they are evidence driven rather than economically driven. However, if a patient's insurance does not cover a particular drug, it is better for the patient and the physician to know this at the time the prescription is written.

This legislation does not prohibit formularies or require pharmacies to dispense all prescriptions and payers to cover all prescriptions. Since formularies exist, it is better for prescribers to know that fact and immediately initiate efforts to obtain coverage for medically necessary exceptions to the formulary rather than to begin the process after coverage is denied to the patient at the pharmacy.

The MMS supports S 483 in the hopes that it will facilitate efficient and improved prescribing.

Follow us on FacebookTwitterLinkedInYouTube

Copyright © 2013. Massachusetts Medical Society, 860 Winter Street, Waltham Woods Corporate Center, Waltham, MA 02451-1411

(781) 893-4610 | (781) 893-3800 | Member Information Hotline: (800) 322-2303 x7311